Lacticaseibacillus rhamnosusFinding
Lacticaseibacillus rhamnosus increases stool frequency
raisesModerate evidenceFinding
01 · The sentence it was drawn from
“The defecation frequency was significantly higher in the L. rhamnosus JYLR-127-administered TRE group compared to the pre-intervention FAC group and the placebo-controlled CDN group (FAC vs. CDN vs. TRE = 2.24 ± 0.72 vs. 2.06 ± 0.70 vs. 3.04 ± 1.54, p < 0.001), with Bristol scoring closer to the median value of 3.50 (FAC vs. CDN vs. TRE = 3.16 ± 0.99 vs. 2.99 ± 0.82 vs. 3.63 ± 0.95, p < 0.01, Figure 2A).”
Lacticaseibacillus rhamnosus
Stool frequency
raises
- Who
- Fracture patients with post-surgery constipation (CSS >= 6, Bristol < 3); TRE probiotic arm versus placebo CDN arm after one week; a pre-intervention FAC group is also compared; p is a three-group ANOVA
- Dose studied
- 4 g/day, twice daily, 2 g per dose, one week
Moderate evidencePMID 38794748 · 2024
02 · The study
- Study
- RCT
- Duration
- 7 days
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
Nutrients04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7G6G8ESKHHKB9BSSBB4F4BV